Table 4 Nested cross-validation results using non-chromosome 21 genes
From: Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart
Pass | Number of samples | Best inner C-V score (% correct) | Number of tied models | Outer C-V score (% correct) |
|---|---|---|---|---|
Subject 1 | 3 | 68.18% (15/22) | 12 | 13.89% |
Subject 2 | 2 | 69.57% (16/23) | 92 | 1.63% |
Subject 3 | 4 | 71.43% (15/21) | 3 | 50.00% |
Subject 4 | 4 | 66.67% (14/21) | 3 | 75.00% |
Subject 5 | 4 | 76.19% (16/21) | 13 | 25.00% |
Subject 6 | 1 | 75.00% (18/24) | 18 | 0.00% |
Subject 7 | 4 | 57.14% (12/21) | 4 | 68.75% |
Subject 8 | 1 | 70.83% (17/24) | 1 | 100.00% |
Subject 9 | 1 | 70.83% (17/24) | 24 | 95.83% |
Subject 10 | 1 | 66.67% (16/24) | 1 | 100.00% |
| Â | Â | Â | Accuracy estimate | 48.63% |